At a glance
ClinicalIndex Comparison RecordN/ACompleted· 34 enrolled
Drug / intervention
MGC Health COVID-19 & Flu A+B Home Multi Test +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study
In Brief
A clinical study evaluating MGC Health COVID-19 & Flu A+B Home Multi Test and MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o) for COVID-19 and 2 related conditions. Completed, enrolled 34 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the usability of the MGC Health COVID-19 \& Flu A+B Home Multi Test in home use.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19, Influenza A, Influenza B
CountriesUnited States
CollaboratorsCSSi Life Sciences
Timeline
N/ACompletedFinished
202420252026
Enrollment StartFeb 2023
First PostedFeb 2023
Primary CompletionFeb 2023
Study CompletionMar 2023
TodayJul 2026
First PostedFeb 17, 2023
Enrollment StartFeb 14, 2023
Primary CompletionFeb 28, 2023
Study CompletionMar 2, 2023
TodayJul 2, 2026
Enrollment to primary: 14 daysPosted 3.4 years ago
Interventions
MGC Health COVID-19 & Flu A+B Home Multi Testother
self-collected direct anterior nares swab samples
MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o)other
adult lay user collected anterior nares swab sample